An ex vivo RNA trans-splicing strategy to correct human generalized severe epidermolysis bullosa simplex.
P PekingJ S BreitenbachM AblingerW H MussF J PoetschkeT KocherU KollerS HainzlS KitzmuellerJ W BauerJulia ReicheltT LettnerVerena WallyPublished in: The British journal of dermatology (2018)
Our data demonstrate that trans-splicing-mediated mRNA therapy is an effective method for the correction of dominantly inherited KRT14 mutations at the transcriptional level. This results in the rescue of the EBS-gen sev phenotype and stabilization of the epidermis in a xenograft mouse model.